Myrbetric 50mg with 30 Tablets (Mirabegron)

Category

Medications for the treatment of urinary disorders

Line

Myrbetric

Brand

Asofarma

Molecule

Mirabegron

Presentation

30 Tablets of 50 mg

Laboratory

Asofarma

Indications

Myrbetric is indicated for the treatment of overactive bladder, which manifests as symptoms such as urinary incontinence, urinary urgency, and increased urinary frequency. This medication acts as a selective beta-3 adrenergic receptor agonist, leading to relaxation of the detrusor muscle of the bladder, thus allowing for greater urine storage and reducing the need for frequent urination. It is important that the use of Myrbetric be part of a comprehensive approach that includes education on bladder health and lifestyle changes when appropriate.

Composition

Each Myrbetric tablet contains 50 mg of Mirabegron as the active ingredient. Additionally, it contains excipients such as lactose monohydrate, corn starch, hypromellose, and other components that facilitate the formulation of the medication.

Contraindications

Myrbetric is contraindicated in patients with known hypersensitivity to Mirabegron or any of the excipients in the formulation. Its use is not recommended in patients with severe renal or hepatic impairment, as well as in those with urinary retention or conditions that may predispose to urinary tract obstruction.

Precautions

Caution should be exercised when administering Myrbetric to patients with a history of hypertension, as the medication may cause an increase in blood pressure. Additionally, it is recommended to monitor renal function in patients treated with this medication. It is essential to inform the doctor of any other medications being taken to avoid interactions.

Storage

Store in a cool, dry place, at a temperature not exceeding 30°C. Keep out of reach of children.

Prescription required.

Consult your doctor.